Medico Remedies Peer Comparison

Medico Remedies Ltd. significantly lags behind its peers in key financial metrics, showing no growth and profitability, while its peers exhibit various degrees of performance. The lack of revenue and profit margins raises concerns about its viability compared to a strong group of competitors in the Pharmaceuticals & Drugs industry.

• • Medico Remedies Ltd. shows zero revenue growth and profitability metrics.
• • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are standout performers with strong growth and profitability.
• • Medico has a high PE ratio with no earnings, indicating potential overvaluation.
• • Divi's Laboratories and Cipla provide good value with strong returns and reasonable valuations.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth (YoY: 8.42%) and strong profitability (ROE: 16.13%).
• • Dr. Reddy's Laboratories Ltd.: Strong profitability metrics (ROE: 21.76%, EBITDA Margin: 27.09%) and significant growth (EPS: 68.07).
• • Cipla Ltd.: Good balance of low PE (23.73) with solid profitability (ROE: 16.63%).
• • Mankind Pharma Ltd.: Excellent revenue growth (YoY: 18.12%) and low debt levels (Debt/Equity: 0.021).